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Valvular Heart Disease 
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• Diagnostic and treatment 
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https://upload.wikimedia.org/wikipedia/commons/b/b4/Aortic_stenosis_rheumatic,_gross_pathology_20G0014_lores.jpg 
Definition  
Valvular heart disease (VHD) is any disease process 
involving one or more of the four valves of the 
heart (the aortic and mitral valves on the left and 
the pulmonary and tricuspid valves on the right). 
 
There are two types of heart valve disease: 
• Valvular stenosis, that occurs when a heart valve 
doesn't fully open due to stiff or fused leaflets. 
• Valvular insufficiency (regurgitation, incompetence, 
"leaky valve“), that occurs when a valve does not close 
tightly 
http://www.webmd.com/heart-disease/guide/heart-valve-disease https://en.wikipedia.org/wiki/Valvular_heart_disease 
US MLE STEP 2 TEST 
A 60-year-old woman is found to have the following 
pressure vs. volume profile in her left ventricle during an 
analysis of her cardiac cycle. See Figure A for a comparison 
of her profile (in red) versus a normal profile (outlined in 
black). Which of the following is most likely to be 
appreciated on auscultation?   
1.  Crescendo-decrescendo systolic ejection murmur,  
2.  Holosystolic, harsh-sounding murmur, 3.  Late systolic 
crescendo murmur, 4.  Continuous machine-like murmur, 
5.  Holosystolic, high-pitched "blowing murmur“.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 5. The diagram shown is consistent 
with mitral regurgitation (mitral insufficiency). Mitral 
regurgitation presents with a holosystolic, high-pitched 
"blowing murmur." 
Incorrect answers: 
1: Crescendo-decrescendo systolic ejection murmurs are 
associated with aortic stenosis (AS), 2: Holosystolic, harsh-
sounding murmurs are associated with ventricular septal 
defects, 3: Late systolic crescendo murmurs are associated 
with mitral valve prolapse, 4: Continuous machine-like 
murmurs are associated with patent ductus arteriosus. 
https://www.mommd.com/usmle1to10.shtml 
Epidemiology 1   
  
http://www.nature.com/nrcardio/journal/v8/n3/fig_tab/nrcardio.2010.202_ft.html https://en.wikipedia.org/wiki/Valvular_heart_disease 
• Valvular heart disease 
occur largely as a result 
of aging.  
• Most people are in 
their late 50s when 
diagnosed, and more 
than one in ten people 
over 75 have it.  
Epidemiology 2   
  
http://www.nature.com/nrcardio/journal/v8/n3/fig_tab/nrcardio.2010.202_ft.html https://en.wikipedia.org/wiki/Valvular_heart_disease 
• Abbreviation: AR, 
aortic regurgitation; 
AS, aortic stenosis; M, 
multiple valve disease; 
MR, mitral 
regurgitation; MS, 
mitral stenosis; R, 
right-sided heart 
disease. 
Risk Factors and Etiology 1   
• Aortic stenosis: calcification of aortic valve, 
rheumatic fever. 
• Aortic regurgitation: 1) acute: infective endocarditis, 
trauma; 2) chronic: 2a) primary valvular: rheumatic 
fever, bicuspid aortic valve, Marfan's 
syndrome, Ehlers–Danlos syndrome, ankylosing 
spondylitis, systemic lupus erythematosus; 2b) 
disease of the aortic root: syphilitic 
aortitis, osteogenesis imperfecta, aortic 
dissection, Behçet's disease, reactive arthritis, 
systemic hypertension.  
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Mechanisms 1 
• Aortic stenosis: obstruction through the aortic 
ostium causes increased pressure in the LV and 
impaired flow through the aorta. 
• Aortic regurgitation: insufficiency of the aortic 
valve causes backflow of blood into the LV. 
• Mitral stenosis:  progressive obstruction of the 
mitral ostium causes increased pressure in the left 
atrium and the pulmonary circulation; congestion 
may cause thromboembolism, and atrial 
hypertension may cause atrial fibrillation.  
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Risk Factors and Etiology 2   
• Mitral stenosis: almost always caused by rheumatic 
heart disease. 
• Mitral regurgitation: 1) acute: endocarditis, 
mainly S. aureus, papillary muscle rupture or 
dysfunction; 2) chronic: rheumatic fever, Marfan's 
syndrome, cardiomyopathy. 
• Tricuspid regurgitation: 1) secondary to right 
ventricular dilation; 2) Other causes: tricuspid 
endocarditis, rheumatic fever, Ebstein's anomaly, 
carcinoid syndrome and myxomatous degeneration. 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Mechanisms 2 
• Mitral regurgitation: insufficiency of the mitral 
valve causes backflow of blood into the left atrium 
during systole. 
• Tricuspid regurgitation: insufficiency of the tricuspid 
valve causes backflow of blood into the right atrium 
during systole. 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Mechanisms 
(Accents on Inflammation) 
http://circresearch.com/gallery/fibrocalcific-aortic-valve-disease-opportunity-to-understand-disease-mechanisms-using-mouse-models/ 
US MLE STEP 2 TEST 
A 50-year-old female presents with a holosystolic murmur 
heard best over the apex, radiating to the axilla. She has no 
signs of pulmonary hypertension or edema. What best 
explains her lack of symptoms?  
1.  The right ventricle is compensating with decreased 
compliance, 2.  The left atrium is compensating with 
increased compliance, 3.  The aorta is compensating with 
increased compliance, 4.  As long as preload in the left 
ventricle is maintained there would be no symptoms, 
5.  There is only a ballooning of the valve which would not 
result in any hemodynamic changes in the heart.  
 
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 2. The patient in this vignette most likely 
has chronic mitral regurgitation, based on her lack of symptoms 
and characteristic murmur. Chronic mitral regurgitation is 
characterized by an increased left atrial compliance. 
 
Incorrect answers: 
1: The right ventricle plays no role in chronic, compensated 
mitral regurgitation, 3: The aorta plays no role in chronic, 
compensated mitral regurgitation, 4: This describes hypertrophic 
obstructive cardiomyopathy which would not present with an 
asymptomatic holosystolic murmur, 5: This describes mitral 
valve prolapse, which would not present with a holosystolic 
murmur (rather a click and murmur). 
https://www.mommd.com/usmle1to10.shtml 
Classification 
(International Classification of Diseases (ICD) 
apps.who.int/classifications/icd10/browse/2016/en#/I46 
 
I34 Nonrheumatic mitral valve disorder 
I35 Nonrheumatic aortic valve disorders 
I36 Nonrheumatic tricuspid valve disorders 
I37 Pulmonary valve disorders 
I38 Endocarditis, valve unspecified 
I39* Endocarditis and heart valve disorders in diseases 
classified elsewhere 
Q22 Congenital malformations of pulmonary&tricuspid valves 
Q23 Congenital malformations of aortic and mitral valves 
Q24 Other congenital malformations of heart 
Q25 Congenital malformations of great arteries 
Classification 
(Types) 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Valve involved Stenotic disease 
Insufficiency/regurgitation 
disease 
Aortic valve Aortic valve stenosis (AS) 
Aortic 
insufficiency/regurgitation (AR) 
 
Mitral valve Mitral valve stenosis (MS) 
Mitral 
insufficiency/regurgitation (MR) 
Tricuspid valve Tricuspid valve stenosis 
Tricuspid 
insufficiency/regurgitation 
Pulmonary valve Pulmonary valve stenosis 
Pulmonary 
insufficiency/regurgitation 
Classification 
(Stages of Progression of VHD) 
http://content.onlinejacc.org/article.aspx?articleid=1838843 
Stage Definition Description 
A At risk Patients with risk factors for development of VHD 
B Progressive 
Patients with progressive VHD (mild-to-moderate 
severity and asymptomatic) 
C 
Asymptomatic 
severe 
Asymptomatic patients who have the criteria for 
severe VHD: 
C1: Asymptomatic patients with severe VHD in 
whom the left or right ventricle remains 
compensated 
C2: Asymptomatic patients with severe VHD with 
decompensation of the left or right ventricle 
D 
Symptomatic 
severe 
Patients who have developed symptoms as a 
result of VHD 
Clinical Investigation 
• Aortic stenosis: heart failure; angina pectoris; 
syncope, usually exertional. 
• Aortic regurgitation: heart failure; palpitations; 
angina pectoris; in acute cases cyanosis. 
• Mitral stenosis: heart failure symptoms. 
• Mitral regurgitation: heart failure symptoms; 
palpitations; pulmonary edema. 
• Tricuspid regurgitation: symptoms of right-sided 
heart failure (ascites, hepatomegaly, edema, jugular 
venous distension, and atc.). 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
US MLE STEP 2 TEST 
A 27-year-old male with a history of injection drug use has 
been feeling short of breath and fatigued for the past 
several weeks. He is having trouble climbing the stairs to his 
apartment and occasionally feels like his heart is racing out 
of control. His past medical history is most notable for a 
previous bout of infective endocarditis after which he was 
lost to follow-up. On exam, you note that his carotid pulse 
has rapid rise and fall. Which of the following would you 
also expect to find?  
1.  Mid-systolic click, 2.  Fixed, split S2, 3.  Venous hum, 
4.  Widened pulse pressure, 5.  Systolic murmur that 
increases with valsalva.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 4. This patient is showing signs and symptoms 
of heart failure. The history of infective endocarditis paired with the 
carotid pulse findings raise suspicion for aortic regurgitation and one 
ought to examine for a widened pulse pressure. 
Incorrect answers: 
1: A mid-systolic click is most commonly associated with mitral valve 
prolapse, 2: A fixed, split S2 is not associated with aortic regurgitation 
but sometimes with a septal defect or pulmonary hypertension, 3: A 
venous hum is most commonly heard with a patent ductus arteriosus, 
5: For testing purposes, Valsalva increases intrathoracic pressure 
thereby decreasing venous return to the heart, and subsequent blood 
flow through the chambers, increasing the murmur in hypertrophic 
cardiomyopathy but decreasing the murmur in aortic regurgitation. 
https://www.mommd.com/usmle1to10.shtml 
Diagnosis 1 
• Aortic stenosis: chest X-ray (calcific aortic valve, 
enlarged LV and atrium); ECG (LV hypertrophy and 
left atrial abnormality; echocardiography (LV 
hypertrophy, thickened and immobile aortic valve 
and dilated aortic root); cardiac chamber 
catheterization (stenosis in valve area ). 
•  Aortic regurgitation: chest X-ray (LV hypertrophy, 
dilated aorta); ECG (LV hypertrophy); 
echocardiogram (dilated left aortic root and reversal 
of blood flow in the aorta).  
 https://en.wikipedia.org/wiki/Valvular_heart_disease 
Diagnosis 2 
• Mitral stenosis: chest X-ray (left atrial enlargement); 
echocardiography (left atrial enlargement, thick and 
calcified mitral valve with narrow and "fish-mouth"-
shaped orifice and signs of right ventricular 
failure in advanced disease). 
• Mitral regurgitation: chest X-ray (dilated LV); 
echocardiography (mitral reverse flow, dilated left 
atrium and LV with decreased LV function). 
• Tricuspid regurgitation: echocardiography (tricuspid 
prolapse or flail), ECG (enlargement of RV and 
atrium). 
 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Diagnosis 
(Echocardiographic Criteria for the Definition of 
Severe Valve Stenosis)  
https://eurheartj.oxfordjournals.org/content/ehj/33/19/2451.full.pdf 
Diagnosis 
(Echocardiographic Criteria for the Definition of 
Severe Valve Regurgitation)  
https://eurheartj.oxfordjournals.org/content/ehj/33/19/2451.full.pdf 
Diagnosis 
(Aortic Stenosis ) 
http://www.inventivemedical.com/wp-content/uploads/2014/10/Pathology-4-aortic-stenosis-Doppler-1.png https://en.wikipedia.org/wiki/Valvular_heart_disease 
Diagnosis 
(Aortic Regurgitation) 
http://1.bp.blogspot.com/-RJ1nkDRY6Rc/TzJPB9zVHsI/AAAAAAAADqM/9tzJ5p0XUJA/s1600/Obraz1.jpg http://www.heart-vessels.com/images/aortic-insufficiency.jpg 
Diagnosis 
(Mitral Stenosis ) 
content.onlinejacc.org/data/Journals/JAC/928699/81619_gr4.jpeg clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/mitral-valve-disease/images/figure-8.jpg 
Diagnosis 
(Mitral Regurgitation) 
herzzentrum.immanuel.de/fileadmin/user_upload/IK_Bernau/03_Abteilungen/03_07_Herzzentrum/03_07_02_Leistungen/02_1_Krankheitsbilder  
Diagnosis 
(Tricuspid Regurgitation) 
http://bestpractice.bmj.com/best-practice/images/bp/en-gb/472-2_default.jpg 
US MLE STEP 2 TEST 
A 58-year-old woman with a history of rheumatic fever has 
been experiencing exertional fatigue and dyspnea. She has 
begun using several pillows at night to sleep and 
occasionally wakes up at night gasping for air. On exam, she 
appears dyspneic and thin. Cardiac exam reveals a loud S1, 
opening snap, and apical diastolic rumble. Which of the 
following is the strongest predictor of the severity of her 
cardiac problem?  
1.  Greater intensity of the diastolic rumble, 2.  Short time 
between A2 and the opening snap, 3.  Presence of a soft P2  
4.  Shorter duration of the diastolic rumble, 5.  Presence of 
rales.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 2. This patient has mitral stenosis. The 
time between A2 and the opening snap is inversely correlated 
with the severity of mitral stenosis. 
Incorrect answers: 
1 & 4: With increasingly severe stenosis, the duration of the 
murmur increases and, in the development of heart failure, the 
intensity of the murmur may actually finally decrease or become 
inaudible, 3: There is accentuation of P2 when pulmonary 
hypertension (a possible sequelae of long-standing mitral 
stenosis) is present, 5: The presence of rales indicates 
pulmonary edema. It may indicate that a patient is experiencing 
left-sided heart failure, but it is not specific to mitral stenosis nor 
the severity of stenosis. 
https://www.mommd.com/usmle1to10.shtml 
Treatment 
(Aortic Stenosis) 1 
• No treatment in asymptomatic patients. 
• If symptomatic, treated with aortic valve 
replacement surgery. 
• Medical therapy and percutaneous balloon 
valvuloplasty have relatively poor effect: 
- any angina is treated with short-acting 
nitrovasodilators, beta-blockers and/or calcium 
blockers;  
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Treatment 
(Aortic Stenosis) 2 
• If Medical therapy and percutaneous balloon 
valvuloplasty have relatively poor effect: 
- any hypertension is treated aggressively, but 
caution must be taken in administering beta-
blockers; 
- Any heart failure is treated with diuretics, 
nitrovasodilators and, if not contraindicated, 
cautious inpatient administration of ACE inhibitors. 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Treatment 
(Aortic Regurgitation) 
• If stable and asymptomatic - conservative treatment 
such as low sodium diet, diuretics, ACE 
inhibitors/angiotensin II receptor 
antagonists, calcium blockers and avoiding very 
strenuous activity. 
• Aortic valve replacement in symptomatic patients 
or progressive LV dilation or systolic ventricular 
diameter >55 mm, immediately if acute. 
• Endocarditis prophylaxis is indicated before dental, 
gastrointestinal or genitourinary procedures.  
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Treatment 
(Mitral Stenosis) 1 
• No therapy is required for asymptomatic patients.  
• Diuretics for any pulmonary congestion or edema. 
• If stenosis is severe, surgery is recommended. 
• Any atrial fibrillation is treated accordingly (rate or 
rrhythm control, and chronic 
anticoagulant administration). 
• Prophylaxis of infective endocarditis .  
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Treatment 
(Mitral Stenosis) 2 
• Surgically, by mitral valvuloplasty with a 
percutaneously inserted balloon, unless significant 
mitral regurgitation or too much calcification 
(indicated in ostium area < 1-1.2 cm2). 
• Other options include valvulotomy or mitral valve 
replacement by open surgery. 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Treatment 
(Mitral Regurgitation) 1 
• Medically:  
• afterload reduction with vasodilators; 
• any hypertension is treated aggressively, e.g. 
by diuretics and low sodium diet; 
• antiarrhythmics; 
• chronic anticoagulation in concomitant mitral 
valve prolapse or atrial fibrillation.  
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Treatment 
(Mitral Regurgitation) 2 
• In acute cases - intra-aortic balloon pump (IABP) as 
temporary solution until surgery. 
• Surgery by either mitral valve repair or mitral valve 
replacement, indicated if very symptomatic (NYHA 
III), ventricular dilation or decreasing ejection 
fraction. 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
US MLE STEP 2 TEST 
A 68-year-old woman is admitted to the hospital following an 
acute change in mental status. She has a mechanical heart valve. 
Her medications are carvedilol, lisinopril, atorvastatin, and 
warfarin. Coagulation studies show an INR of 3.1, which is within 
the target range set by her cardiologist. For which of the 
following comorbid medical conditions would this medical 
regimen and INR be most appropriate?  
1.  Mechanical aortic valve with hyperlipidemia, 2.  Mechanical 
aortic valve with atrial fibrillation, 3.  Mechanical aortic valve 
with diabetes mellitus, 4.  Mechanical aortic valve with 
hypertension, 5.  Mechanical aortic valve with history of 
systemic embolization.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 2. The patient described in the question stem 
has a mechanical heart valve and an INR of 3.1. INR of 2.5-3.5 is 
recommended for patients with a bileaflet mechanical aortic valve 
and atrial fibrillation. 
Incorrect answers: 
1: INR of 2-3 is indicated for a bileaflet mechanical aortic valve, 3: The 
presence of diabetes is not the most important factor determining the 
appropriate level of anticoagulation for this patient. Answer 2 is a 
better answer, 4: The presence of hypertension is not the most 
important factor determining the appropriate level of anticoagulation 
for this patient. Answer 2 is a better answer, 5: INR of 2.5-3.5 + ASA is 
indicated for a mechanical valve with a history of systemic 
embolization. The patient is not taking aspirin.  
https://www.mommd.com/usmle1to10.shtml 
Treatment 
(Tricuspid Regurgitation) 
• Treatment of underlying cause. 
• Surgery: 
– tricuspid valvular repair; 
–Valvuloplasty; 
– valve replacement(rarely performed). 
https://en.wikipedia.org/wiki/Valvular_heart_disease 
Treatment 
(Prosthetic Heart Valves) 1 
• Bioprosthetic valves used in 
heart valve replacement 
generally offer functional 
properties (e.g., 
hemodynamics, resistance to 
thrombosis) that are more 
similar to those of native 
valves.   
http://emedicine.medscape.com/article/780702-overview 
Treatment 
(Prosthetic Heart Valves) 2 
• Implantation of prosthetic 
cardiac valves to treat 
hemodynamically significant 
aortic or mitral valve disease 
has become increasingly 
common. 
http://emedicine.medscape.com/article/780702-overview 
US MLE STEP 2 TEST 
A 53-year-old man from Guatemala presents with a 6-month 
history of progressively worsening dyspnea on exertion and 
cough, which has led to marked limitation of his physical activity. 
As a child, he had a febrile illness characterized by arthritis 
affecting multiple joints and abnormal movements. On cardiac 
exam, he has a low-pitched diastolic rumble that is most 
prominent at the apex. Subsequent workup with 
echocardiogram confirms the diagnosis of a valvular 
abnormality. What is the best treatment option?  
1.  Mitral valve repair, 2.  Medical management with diuretics, 
3.  Closed mitral commissurotomy, 4.  Percutaneous mitral 
balloon valvotomy, 5.  Open mitral commissurotomy.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 4. This patient has rheumatic heart disease and 
severe mitral stenosis with New York Heart Association (NYHA) class 
III symptoms. With favorable valvular anatomy, percutaneous mitral 
balloon valvotomy would be appropriate treatment. 
Incorrect answers: 
1-3,5: These are all potential treatment approaches; however, in 
direct trials comparing percutaneous mitral balloon valvotomy to 
surgical commissurotomy, the former performed as good or better 
than the latter. There is less data comparing PMBV versus mitral valve 
repair, but it is still considered a first-line option. Medical therapy can 
provide symptomatic relief but does not alter the underlying 
pathophysiology. 
https://www.mommd.com/usmle1to10.shtml 
Treatment 
(Prosthetic Heart Valves Malfunction) 1 
• Acute prosthetic valve failure: sudden onset of 
dyspnea, syncope, or precordial pain. 
• Acute aortic valve failure: sudden death; survivors 
have acute severe dyspnea, sometimes 
accompanied by precordial pain, or syncope. 
• Subacute valvular failure: symptoms of gradually 
worsening congestive heart failure; they also may 
present with unstable angina or, at times, may be 
entirely asymptomatic.  
http://emedicine.medscape.com/article/780702-overview 
Treatment 
(Prosthetic Heart Valves Malfunction) 2 
• Embolic complications: symptoms related to the 
site of embolization (e.g., stroke, myocardial 
infarction, sudden death, or symptoms of visceral or 
peripheral embolization). 
• Anticoagulant-related hemorrhage: symptoms 
related to the site of hemorrhage. 
http://emedicine.medscape.com/article/780702-overview 
Prognosis  
• The prognosis for patients with valvular heart 
disease has improved over the past 15 years.  
• A better understanding of the proper timing of 
surgery is one of the key reasons.  
• In general, surgery for stenotic valvular disease can 
be delayed until symptoms appear.  
• In regurgitant valvular heart disease, prognostically 
important left ventricular dysfunction may develop 
in the absence of symptoms, and thus valve surgery 
for asymptomatic patients is entirely appropriate.  
http://www.nejm.org/doi/full/10.1056/NEJM199707033370107 
Prophylaxis 
• Prompt treatment of strep infections can prevent 
rheumatic fever, which damages the heart valves. 
• An exercise, a heart-healthy diet, and medicines 
that lower cholesterol might prevent aortic stenosis 
(thickening and stiffening of the aortic valve).   
• Heart-healthy eating, physical activity, other heart-
healthy lifestyle changes, and medicines aimed at 
preventing a heart attack, high blood pressure, 
or heart failure also may help prevent heart valve 
disease. 
https://www.nhlbi.nih.gov/health/health-topics/topics/hvd/prevention 
Abbreviations  
ACE - angiotensin converting 
enzyme 
AR – aortic regurgitation 
AS - aortic valve stenosis  
ECG - electrocardiogram  
ERO - effective regurgitant 
orifice 
IABP - intra-aortic balloon 
pump 
IE - infective endocarditis 
LA  - left atrium 
 
  
LVEF - left ventricular ejection 
fraction 
LVESD - left ventricular end-
systolic dimension 
MS - mitral valve stenosis  
MVA - mitral valve area 
PAWP pulmonary artery wedge 
pressure 
MR – mitral regurgitation 
PR – pulmonary 
regurgitation 
VHD - valvular heart disease  
 
Diagnostic and treatment guidelines 
2014 AHA/ACC Guideline for the Management of Patients With 
Valvular Heart Disease 
Guidelines on the management of valvular heart disease (version 
2012) 
Prosthetic Heart Valves 
 
Infective Endocarditis 
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• Abbreviations  
• Diagnostic and treatment 
guidelines 
https://mileon.files.wordpress.com/2010/07/sin-titulo4.png 
Definition  
Infective endocarditis (IE) is a potentially lethal 
disease caused largely by bacteria that enter the 
bloodstream and settle in the heart, which may 
include one or more heart valves, the mural 
endocardium, or a septal defect or a blood vessel, 
with intracardiac effects that include severe valvular 
insufficiency and intractable congestive heart failure 
and myocardial abscesses.   
emedicine.medscape.com/article/216650-overview circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
US MLE STEP 2 TEST 
A 58-year-old man presents to the doctor with recurring 
fevers, night sweats and malaise. On exam he is found to 
have a holosystolic murmur heard loudest over the apex. His 
dermatologic exam is notable for painless skin lesions shown 
in Figure 1. Which of the following heart conditions most 
likely predisposed him to his current condition?            
1.  Bicuspid aortic valve, 2.  Aortic stenosis, 3.  Mitral 
stenosis, .  Mitral valve prolapse, 5.  Rheumatic heart 
disease.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 4.  The clinical presentation is consistent 
with native valve bacterial endocarditis (NVBE). The most 
common cardiac abnormality predisposing to NVBE in 15- to 60-
year olds is mitral valve prolapse (MVP). 
Incorrect answers: 
1, 2, 3: These cardiac conditions do not directly increase the risk 
of IE, 5: Although rheumatic heart disease is associated with IE, 
mitral valve prolapse is the most common cardiac condition that 
predisposes patients to NVBE. 
 
https://www.mommd.com/usmle1to10.shtml 
Epidemiology 1   
  
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
• IE is an uncommon infectious disease with an 
annual incidence ranging from 3 to 7 per 100000 
person-years in the most contemporary population 
surveys. 
• Although relatively rare, IE continues to be 
characterized by increased morbidity and mortality 
and is now the third or fourth most common life-
threatening infection syndrome, after sepsis, 
pneumonia, and intra-abdominal abscess.   
Epidemiology 2   
  
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
• Characteristics of IE patients have shifted toward an 
increased mean patient age, a higher proportion of 
prosthetic valves and other cardiac devices, and a 
decreasing proportion of rheumatic heart disease.  
• The proportion of IE patients undergoing surgery 
has increased over time to reach ≈50%. 
Risk Factors 
• Artificial heart valves. 
• Intracardiac devices. 
• Unrepaired cyanotic congenital heart defects. 
• History of infective endocarditis. 
• Chronic rheumatic heart disease.  
• Age-related degenerative valvular lesions. 
• Hemodialysis. 
• Coexisting conditions, especially ones that suppress 
immunity (diabetes mellitus, alcohol 
abuse, HIV/AIDS, and intravenous drug). 
https://en.wikipedia.org/wiki/Infective_endocarditis 
Etiology   
• Many microorganisms can cause infective 
endocarditis.  
• These are generally isolated by blood culture, 
where the patient's blood is removed, and any 
growth is noted and identified.  
• The term bacterial endocarditis (BE) commonly is 
used, reflecting the fact that most cases of IE are 
due to bacteria; however, infective endocarditis (IE) 
has become the preferred term. 
https://en.wikipedia.org/wiki/Infective_endocarditis 
Etiology 
(Bacterial) 1 
• Staphylococcus aureus followed by Streptococci of 
the viridans group and coagulase negative 
Staphylococci are the three most common 
organisms responsible for infective endocarditis.  
• Other Streptococci and Enterococci are also a 
frequent cause of infective endocarditis.   
• Enterococcus can enter the bloodstream as a 
consequence of abnormalities in the 
gastrointestinal or genitourinary tracts.  
https://en.wikipedia.org/wiki/Myocarditis#Causes 
Etiology 
(Bacterial) 2 
• Some organisms, when isolated, give valuable clues 
to the cause, as they tend to be specific. 
• Less commonly reported etiological bacteria are 
Pseudomonas, S. bovis, Clostridium septicum, 
Bartonella, Chlamydia psittaci, Coxiella etc.  
https://en.wikipedia.org/wiki/Myocarditis#Causes 
Etiology 
(Fungal) 
• Candida albicans, a yeast, is associated with 
endocarditis in IV drug users 
and immunocompromised patients. 
• Other fungi demonstrated to cause endocarditis 
are Histoplasma capsulatum and Aspergillus. 
• Endocarditis with Tricosporon asahii has also been 
reported. 
https://en.wikipedia.org/wiki/Myocarditis#Causes 
US MLE STEP 2 TEST 
A 32-year-old African American woman presents to her family 
physician complaining of fevers, fatigue, weight loss, night sweats 
and a rash on her face that extends over the bridge of her nose. 
She has no significant past medical history. She denies tobacco, 
alcohol, and illicit drug use. If she were found to have a cardiac 
lesion, what would be the most likely pathogenetic cause? 
1.  Bacteremia secondary to a recent dental procedure,  
2.  Abberent flow causing platelet-fibrin thrombus formation 
secondary to hypercoagulability and maliganncy, 3.  Bacteremia 
secondary to an acute infection from an indwelling catheter, 
4.  Immune complex deposition and subsequent inflammation, 
5.  Left atrial mass causing a ball valve-type outflow obstruction.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 4.  This patient's signs and symptoms point to a 
diagnosis of systemic lupus erythematosus (SLE). Libman-Sacks 
endocarditis is a sterile/inflammatory endocarditis that is commonly 
associated finding with SLE.  
Incorrect answers: 
1: Subacute bacterial endocarditis would not be expected in a patient 
with lupus without other incriminating historical data, 2: Nonbacterial 
thrombotic endocarditis, also known as marantic endocarditis, is a 
paraneoplastic syndrome seen most often with primary GI cancers. 
These may cause emboli to the periphery, 3: Acute bacterial 
endocarditis is usually caused by S. aureus in IV drug abusers, 5: Atrial 
myxomas are benign cardiac tumors that would not be expected to be 
seen in a patient with lupus. 
https://www.mommd.com/usmle1to10.shtml 
Mechanisms 1  
http://emedicine.medscape.com/article/216650-overview#a3 https://en.wikipedia.org/wiki/Myocarditis#Causes 
• Damaged valves and endocardium contribute to the 
development of IE. 
• The damaged part of a heart valve forms a 
local blood clot, a condition known as non-bacterial 
thrombotic endocarditis (NBTE); the platelet and 
fibrin deposits that form as part of the blood 
clotting process allow bacteria to take hold and 
form vegetations.  
Mechanisms 2  
http://emedicine.medscape.com/article/216650-overview#a3 https://en.wikipedia.org/wiki/Myocarditis#Causes 
• Damage to the valves and endocardium can be 
caused by altered, turbulent blood flow, more likely 
in high pressure areas; catheters, electrodes, and 
other intracardiac prosthetic devices; solid particles 
from repeated intravenous injections, chronic 
inflammation.  
• The complications of acute BE result from 
intracardiac disease and metastatic infection 
produced by suppurative emboli.  
• Because of their shortened course, immunological 
phenomena are not a part of acute IE. 
Mechanisms 3    
(pathogen–host interaction and risk states) 
http://www.nature.com/nrcardio/journal/v11/n1/fig_tab/nrcardio.2013.174_F1.html 
US MLE STEP 2 TEST 
A 35-year-old woman with a medical history significant for 
asthma, hypertension, and occasional IV drug use comes to 
the emergency department with fever. On physical exam, 
there are findings depicted in figure A, for which the patient 
cannot account. What test will be most helpful to establish 
the diagnosis?         
1.  Echocardiography, 2.  Chest X-ray, 3.  Pulmonary function 
tests, 4.  Electrocardiogram (EKG), 5.  CT pulmonary 
angiography.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 1.   Fever, subungual splinter hemorrhages (in 
image A), and history of IV drug abuse raise concern for infective 
endocarditis. An echocardiogram will likely confirm the diagnosis by 
demonstrating a valvular vegetation. 
Incorrect answers: 
2. Chest X-Ray can occasionally reveal important diagnostic clues (e.g. 
septic pulmonary emboli) but would not show a valve vegetation, which 
indicates active endocarditis, 3. Pulmonary function tests would help 
diagnose asthma, but not infective endocarditis, 4. EKGs rarely reveal 
diagnostic findings of infective endocarditis, but may help determine the 
presence of emboli to the coronary circulation if there are ischemic 
changes, 5. CT pulmonary angiography would help diagnose pulmonary 
embolus (PE), but not infective endocarditis. Sometimes PE is a 
complication of infective endocarditis, but unlikely in the patient in this 
scenario. 
https://www.mommd.com/usmle1to10.shtml 
Classification 
(International Classification of Diseases (ICD)) 
apps.who.int/classifications/icd10/browse/2016/en#/I46 
 
133 Acute and subacute endocarditis 
 I33.0 Acute and subacute infective endocarditis 
           Endocarditis (acute)(subacute):bacterial  
  infective NOS, lenta, malignant, septic, 
ulcerative. 
  I33.9 Acute endocarditis, unspecified. 
 
Classification 
(the Rate of Progression and Severity of Disease) 1 
http://www.merckmanuals.com/professional/cardiovascular-disorders/endocarditis/infective-endocarditis https://en.wikipedia.org/wiki/Infective_endocarditis 
• Subacute bacterial endocarditis (SBE) is often due 
to streptococci of low virulence (mainly viridans 
streptococci) and mild to moderate illness which 
progresses slowly over weeks and months and has 
low propensity to hematogenously seed 
extracardiac sites.  
Classification 
(the Rate of Progression and Severity of Disease) 2 
http://www.merckmanuals.com/professional/cardiovascular-disorders/endocarditis/infective-endocarditis https://en.wikipedia.org/wiki/Infective_endocarditis 
• Acute bacterial endocarditis (ABE) is 
a fulminant illness over days to weeks, and is more 
likely due to Staphylococcus aureus which has much 
greater virulence, or disease-producing capacity 
and frequently causes metastatic infection. 
• Prosthetic valvular endocarditis (PVE) develops in 2 
to 3% of patients within 1 yr. after valve 
replacement and in 0.5%/yr. thereafter.    
Classification 
(the Rate of Progression and Severity of Disease) 3 
http://www.merckmanuals.com/professional/cardiovascular-disorders/endocarditis/infective-endocarditis https://en.wikipedia.org/wiki/Infective_endocarditis 
• The terms short incubation (meaning less than 
about six weeks), and long incubation (greater than 
about six weeks) are preferred. 
Clinical Investigation  
(Signs and Symptoms) 1 
• Fever (97% of patients), malaise and 
endurance fatigue (90% of patients). 
• A new or changing heart murmur, weight loss, and 
coughing (35% of patients).  
• Vascular phenomena: septic embolism (causing 
stroke or gangrene of fingers), Janeway 
lesions (painless hemorrhagic cutaneous lesions on 
the palms and soles), intracranial 
hemorrhage, conjunctival and splinter 
hemorrhages, kidney and splenic infarcts.  
https://en.wikipedia.org/wiki/Infective_endocarditis 
Clinical Investigation  
(Signs and Symptoms) 2 
• Immunologic 
phenomena: glomerulonephritis , Osler's 
nodes (painful subcutaneous lesions in the distal 
fingers), Roth's spots on the retina, positive 
serum rheumatoid factor) 
• Other signs: night sweats, rigors, anemia, etc. 
https://en.wikipedia.org/wiki/Infective_endocarditis 
Clinical Investigation  
(Janeway lesions) 
https://s-media-cache-ak0.pinimg.com/736x/89/bc/e9/89bce950c573e31574d2ebf4731ec3a7.jpg 
Clinical Investigation  
(Skin Lesions) 
http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/infectious-disease/infective-endocarditis/ 
Clinical Investigation  
(Osler's Nodes) 
http://yxzl.baiduyy.com/chm11/jzyxtp/Ch.13_files/image012.jpg 
Clinical Investigation  
(Roth's spots) 
http://medlibes.com/uploads/Screen%20shot%202010-07-17%20at%205.12.22%20PM.png 
Clinical Investigation  
(Sub-acute IE clinical symptoms) 
http://image.slidesharecdn.com/infectiveendocarditis-130201001609-phpapp02/95/infective-endocarditis-11-638.jpg?cb=1359678043 
US MLE STEP 2 TEST 
A 63-year-old female recovering from a total shoulder 
arthroplasty completed 6 days ago presents complaining of 
joint pain in her repaired shoulder. Temperature is 39 degrees 
Celsius. Physical examination demonstrates erythema and 
significant tenderness around the incision site. Wound 
cultures reveal Gram-positive cocci that are resistant to 
nafcillin. Which of the following organisms is the most likely 
cause of this patient's condition?   
1.  Streptococcus viridans, 2.  Escherichia coli, 
3.  Staphylococcus epidermidis, 4.  Staphylococcus aureus  
5.  Streptococcus pyogenes.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 4.  Methicillin-resistant Staphylococcus aureus 
(MRSA) is the likely causative organism in this patient's presentation. It 
is an increasingly common and dangerous nosocomial infection, 
especially in open-joint arthoplasty procedures. It is not susceptible to 
nafcillin/methicillin.  
Incorrect answers: 
1: S. viridans is a common cause of endocarditis; it is not a common 
nosocomial infection that exhibits nasal colonization, 2: Fecal-oral 
transmission is common in E. coli infections, 3: S. epidermidis is found as 
part of the normal skin flora; it is not as common of a causative 
organism in nosocomial infections as S. aureus. It typically is the cause 
of hardware infections in subacute cases, 5: S. pyogenes (or Group A 
Streptococcus) is a common cause of pharyngitis; it is not as common as 
S. aureus in nosocomial infections. 
https://www.mommd.com/usmle1to10.shtml 
Diagnosis 1 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
• The diagnosis of IE is straightforward in the minority 
of patients who present with a consistent history 
and classic oslerian manifestations: sustained 
bacteremia or fungemia, evidence of active 
valvulitis, peripheral emboli, and immunological 
vascular phenomena.  
• In most patients, however, the “textbook” history 
and physical examination findings may be few or 
absent.   
Diagnosis 2 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
• Acute IE may evolve too quickly for the 
development of immunological vascular 
phenomena, which are more characteristic of the 
later stages of the more insidious subacute form of 
untreated IE.  
• The variability in clinical presentation of IE and the 
importance of early accurate diagnosis require a 
diagnostic strategy that is both sensitive for disease 
detection and specific for its exclusion across all 
forms of the disease.   
Diagnosis 3 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
• In 1994, Durack and colleagues23 from the Duke 
University Medical Center proposed a diagnostic 
schema that stratified patients with suspected IE 
into 3 categories: definite, possible, and rejected 
cases. 
Diagnosis 
(the Modified Duke Criteria: Definite, Possible, 
and Rejected Cases) 1 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Definite IE  
 Pathological criteria: microorganisms 
demonstrated by culture or histological examination 
of a vegetation, a vegetation that has embolized, or 
an intracardiac abscess specimen; or pathological 
lesions; vegetation or intracardiac abscess confirmed 
by histological examination showing active 
endocarditis. 
  Clinical criteria: 2 Major criteria, 1 major 
criterion and 3 minor criteria, or 5 minor criteria.  
Diagnosis 
(the Modified Duke Criteria: Definite, Possible, 
and Rejected Cases) 2 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Possible IE  
 1 Major criterion and 1 minor criterion, or 3 
minor criteria  
Rejected  
 Firm alternative diagnosis explaining evidence of 
IE; or resolution of IE syndrome with antibiotic 
therapy for ≤4 d; or no pathological evidence of IE at 
surgery or autopsy with antibiotic therapy for ≤4 d; or 
does not meet criteria for possible  
IE as above IE indicates infective endocarditis.  
Diagnosis 
(the Modified Duke Criteria: Major Criteria)  
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Blood culture positive for IE (2 separate blood cultures: Viridans 
streptococci, Streptococcus bovis, HACEK (Haemophilus species, 
Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, 
and Kingella species) group, Staphylococcus aureus; or community-
acquired enterococci in the absence of a primary focus, or microorganisms 
consistent with IE from persistently positive blood cultures defined as 
follows: at least 2 positive cultures of blood samples drawn >12 h apart or 
all 3 or a majority of ≥4 separate cultures of blood (with first and last 
sample drawn at least 1 h apart).  
Single positive blood culture for Coxiella burnetii or anti–phase 1 IgG 
antibody titer ≥1:800.  
Evidence of endocardial involvement  (echocardiogram positive for IE (TEE 
recommended for patients with prosthetic valves, rated at least possible IE 
by clinical criteria, or complicated IE).  
Diagnosis 
(the Modified Duke Criteria: Minor Criteria)  
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Predisposition, predisposing heart condition, or IDU (injection drug 
use) 
Fever, temperature >38°C. 
Vascular phenomena, major arterial emboli, septic pulmonary 
infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival 
hemorrhages, and Janeway lesions. 
Immunological phenomena: glomerulonephritis, Osler nodes, Roth 
spots, and rheumatoid factor. 
Microbiological evidence: positive blood culture but does not meet 
a major criterion as noted above (excludes single positive cultures 
for coagulase negative staphylococci and organisms that do not 
cause endocarditis) or serological evidence of active infection with 
organism consistent with IE. 
Diagnosis 
(Laboratory Investigations and Biomarkers) 1 
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319 
• Sepsis severity may be indicated by the 
demonstration of a number of laboratory 
investigations, including the degree of 
leucocytosis/leucopoenia, the number of immature 
white cell forms, concentrations of C-reactive 
protein (CRP) and procalcitonin, erythrocyte 
sedimentation rate (ESR) and markers of end-organ 
dysfunction (lactataemia, elevated bilirubin, 
thrombocytopenia and changes in serum creatinine 
concentration); however, none are diagnostic for IE.  
Diagnosis 
(Laboratory Investigations and Biomarkers) 2 
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319 
• Further, certain laboratory investigations are used in 
surgical scoring systems relevant to risk 
stratification in patients with IE, including bilirubin, 
creatinine and platelet count and creatinine 
clearance.  
• The pattern of increase in inflammatory mediators 
or immune complexes may support, but not prove, 
the diagnosis of IE.   
Diagnosis 
(Imaging Techniques) 1 
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319 
• Imaging plays a key role in both the diagnosis and 
management of IE.  
• Echocardiography is useful for the prognostic 
assessment of patients with IE, for its follow-up 
under therapy and during and after surgery. 
• Echocardiography is particularly useful for initial 
assessment of the embolic risk and in decision 
making in IE.  
Diagnosis 
(Imaging Techniques) 2 
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319 
• Transoesophageal echocardiography (TEE) plays a 
major role both before and during surgery 
(intraoperative echocardiography).  
• The evaluation of patients with IE is no longer 
limited to conventional echocardiography, but 
should include several other imaging techniques 
such as magnetic resonance imaging 
(MRI), positron emission tomography 
(PET)/computed tomography (CT), etc. 
US MLE STEP 2 TEST 
A 14-year-old Caucasian male presents with painful 
erythematous and honey-colored crusted lesions around his 
mouth. Culture of the lesions reveals gram-positive cocci in 
clusters. Further analysis reveals bacteria that are beta-
hemolytic, coagulase positive, and appear golden on the 
blood agar plate. Which of the following helps the bacterium 
in this infection bind to immunoglobulin and prevent 
phagocytosis when invading its host?  
1.  Protein A, 2.  Staphylokinase, 3.  Exfoliatin A, 4.  Protein M  
5.  Neurotoxin.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 1.  The patient described above has a 
Staphylococcus aureus skin infection (impetigo) as evidenced by the 
description of the lesion and causative bacteria. Protein A is present on 
the surface of S. aureus and is able to bind to the Fc region of 
immunoglobulin molecules. This region of the immunoglobulin is 
normally bound by phagocytic cells in order to absorb opsonized 
bacteria; protein A disrupts this action and prevents phagocytosis. 
Incorrect answers: 
2: Staphylokinase, like streptokinase, leads to the breakdown of fibrin 
clots, 3: Exfoliatin A leads to the breakdown of desmosomes and can 
lead to scalded skin syndrome, 4: Protein M is a surface protein on 
Streptococcus pyogenes that helps the bacterium avoid phagocytosis, 5: 
Neurotoxin would be consistent with a Clostridium botulinum infection 
(botulinum toxin).  
https://www.mommd.com/usmle1to10.shtml 
Diagnosis 
(Echocardiography as the Reference Method)  
http://eurheartj.oxfordjournals.org/content/35/10/624 
Large vegetation on the posterior mitral leaflet (arrow)  (A)-  
two-dimensional echocardiography, (B) three-dimensional 
echocardiography. LA, left atrium; LV, left ventricle; Ao, aorta; 
AML, anterior mitral leaflet; PML, posterior mitral leaflet. 
Diagnosis 
(Cardiac Computed Tomography)  
https://bjcardio.co.uk/2012/03/aortic-root-fistula-complicating-infective-endocarditis-role-of-64-multi-detector-ct-cardiac-angiography/ 
Cardiac computed tomography (CT). The abscess 
cavity (hollow arrow) communicates with the aortic 
root (F1) and LV outflow tract (F2) to form a fistula 
Diagnosis 
(the Diagnostic Use of Echocardiography)  
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Diagnosis 
(Differential)  
http://patient.info/doctor/systemic-lupus-erythematosus-pro 
• Systemic Lupus Erythematosus. 
• Cardiac tumours, e.g. atrial myxoma. 
• Lyme disease. 
• Antiphospholipid syndrome. 
• Polymyalgia rheumatica. 
• Reactive arthritis. 
Treatment 
(Antimicrobial Therapy: Principles) 1 
• The primary goal of antibiotic treatment is to 
eradicate infection, including sterilizing vegetations, 
although the unique characteristics of infected 
vegetations (focal infection with high bacterial 
density, slow rate of bacterial growth within 
biofilms, and low microorganism metabolic activity, 
impaired immunity ) can pose a variety of 
challenges.   
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Antimicrobial Therapy: Principles) 2 
• Antibiotics may fail to eradicate infection as a result 
of increased binding of the drug to serum proteins, 
perturbations of antibiotic penetration into the 
vegetation, and unique antibiotic 
pharmacokinetic/pharmacodynamic (PK/PD) 
features. 
• Therefore, prolonged, parenteral, bactericidal 
therapy is required for attempted infection cure. 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Antimicrobial Therapy: Inoculum Effect) 1 
• The effect of high bacterial densities on 
antimicrobial activity is called the inoculum effect in 
which certain groups of antimicrobials commonly 
used to treat IE such as β-lactams and glycopeptides 
(and, to a lesser extent, lipopeptides such as 
daptomycin) are less active against highly dense 
bacterial populations.  
 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Antimicrobial Therapy: Inoculum Effect) 2 
• The effective minimum inhibitory concentration 
(MIC) at the site of infection with bacterial densities 
of 108 to 1011 colony-forming units per 1 g tissue 
can be much higher than anticipated by in vitro 
susceptibility tests that use a standard inoculum 
(105.5 colony-forming units per milliliter).  
 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Antimicrobial Therapy: Bactericidal Drugs) 1 
• Data from clinical investigations support the need 
for bactericidal antibiotics to sterilize vegetations in 
IE with high bacterial densities. 
• For enterococci, bactericidal activity can be 
achieved by the combination of certain β-lactam 
antibiotics (e.g., penicillin, ampicillin, and 
piperacillin) with an aminoglycoside.   
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Antimicrobial Therapy: Bactericidal Drugs) 2 
• The bactericidal effect achieved by a combination of 
antibacterial drugs that alone only inhibit bacterial 
growth is called synergy.  
• The rate of bactericidal activity against some other 
organisms can also be enhanced by a combination 
of a β-lactam antibiotic plus an aminoglycoside. 
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Antimicrobial Therapy: Duration) 1 
• The duration of therapy in IE must be sufficient to 
ensure complete eradication of microorganisms 
within vegetations.  
• When the bactericidal activity is known to be more 
rapid or the likely vegetation bacterial burden is 
lower, then the clinician may prescribe a shorter 
duration of antimicrobial therapy in unique 
instances.   
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Antimicrobial Therapy: Duration) 2 
• Combination therapy with penicillin or ceftriaxone 
and an aminoglycoside for 2 weeks is highly 
effective in viridans group streptococci (VGS) IE in 
very select patients with uncomplicated infection.  
• Both β-lactam therapy alone and combination 
therapy with nafcillin and an aminoglycoside for 
only 2 weeks have been effective in patients with 
uncomplicated right-sided IE caused by S aureus; 
monotherapy with a β-lactam would be selected for 
use in cases of uncomplicated IE.  
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
US MLE STEP 2 TEST 
A 68-year-old woman is admitted to the hospital following an 
acute change in mental status. She has a mechanical heart 
valve. Her medications are carvedilol, lisinopril, atorvastatin, 
and warfarin. Coagulation studies show an INR of 3.1, which is 
within the target range set by her cardiologist. For which of 
the following comorbid medical conditions would this medical 
regimen and INR be most appropriate?  
1.  Mechanical aortic valve with hyperlipidemia,  
2.  Mechanical aortic valve with atrial fibrillation, 
3.  Mechanical aortic valve with diabetes mellitus, 
4.  Mechanical aortic valve with hypertension, 5.  Mechanical 
aortic valve with history of systemic embolization.  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is 2.  The patient described in the question stem has 
a mechanical heart valve and an INR of 3.1. INR of 2.5-3.5 is 
recommended for patients with a bileaflet mechanical aortic valve and 
atrial fibrillation. 
Incorrect answers: 
1: INR of 2-3 is indicated for a bileaflet mechanical aortic valve, 3: The 
presence of diabetes is not the most important factor determining the 
appropriate level of anticoagulation for this patient. Answer 2 is a better 
answer, 4: The presence of hypertension is not the most important 
factor determining the appropriate level of anticoagulation for this 
patient. Answer 2 is a better answer, 5: INR of 2.5-3.5 + ASA is indicated 
for a mechanical valve with a history of systemic embolization. The 
patient is not taking aspirin.  
https://www.mommd.com/usmle1to10.shtml 
Treatment 
(Fungi) 
• Fungal IE is rare but can develop in a wide range of 
patients. 
• A 2-phase treatment of fungal IE has evolved. The 
initial or induction phase consists of control of 
infection. Treatment includes a combination of a 
parenteral antifungal agent, usually an 
amphotericin B–containing product, and valve 
surgery.  
• Antifungal therapy usually is given for >6 weeks. 
 http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Long-Term Follow-Up) 1 
• Months to years after completion of medical 
therapy for IE, patients should have ongoing 
observation for and education about recurrent 
infection and delayed onset of worsening valve 
dysfunction. 
• Daily dental hygiene should be stressed, with serial 
evaluations by a dentist who is familiar with this 
patient population.   
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(Long-Term Follow-Up) 2 
• Patients should be questioned about symptoms of 
heart failure, and a thorough physical examination 
should be done.  
• Additional evaluation with echocardiography is 
indicated in selected patients with positive findings 
from history and physical examination.  
• Patients should be instructed to seek immediate 
medical evaluation for persistent fever.  
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296 
Treatment 
(The ‘Endocarditis Team’) 1 
• IE is not a single disease, but rather may present 
with very different aspects depending on the first 
organ involved, the underlying cardiac disease (if 
any), the microorganism involved, the presence or 
absence of complications and the patient's 
characteristics, so no single practitioner will be able 
to manage and treat it.  
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319 
Treatment 
(The ‘Endocarditis Team’) 2 
•  Very high level of expertise is needed from 
practitioners from several specialties, including 
cardiologists, cardiac surgeons, internal diseases 
specialists, microbiologists, neurologists, 
neurosurgeons, experts in coronary heart disease 
and others. 
• About half of the patients with IE undergo surgery 
during the hospital course. 
http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319 
Prognosis 1 
• Prognosis largely depends on whether or not 
complications develop.  
• If left untreated, IE is generally fatal.  
• Early detection and appropriate treatment of this 
uncommon disease can be lifesaving.  
• The overall mortality rate has remained stable at 
14.5%.  
http://emedicine.medscape.com/article/216650-overview#a6 
Prognosis 2 
• Increased mortality rates are associated with 
increased age, infection involving the aortic valve, 
development of congestive heart failure, central 
nervous system (CNS) complications, and 
underlying disease such as diabetes mellitus 
• Acute endocarditis due to S aureus is associated 
with a high mortality rate (30-40%), except when it 
is associated with IV drug use. 
http://emedicine.medscape.com/article/216650-overview#a6 
Prophylaxis 1 
• There is no clinical evidence that it reduces the 
incidence of IE and there are negative effects (e.g. 
allergy and increased bacterial resistance) of taking 
antibiotics that may outweigh the benefits. 
• Antibiotics were historically commonly 
recommended to prevent IE in those with heart 
problems undergoing dental procedures (known 
as dental antibiotic prophylaxis) and in now days 
they are less commonly recommended for this 
procedure.  
http://www.merckmanuals.com/professional/cardiovascular-disorders/endocarditis/infective-endocarditis https://www.nice.org.uk/guidance/published?type=cg 
Prophylaxis 2 
• Preventive dental examination and therapy before 
surgery to repair heart valves or congenital heart 
lesions is recommended. 
http://www.merckmanuals.com/professional/cardiovascular-disorders/endocarditis/infective-endocarditis https://www.nice.org.uk/guidance/published?type=cg 
Key Points 1 
• Because the normal heart is relatively resistant to 
infection, endocarditis occurs when there is a 
predisposing abnormality of the endocardium. 
• Predisposing abnormalities include congenital heart 
defects, rheumatic valvular disease, bicuspid or 
calcific aortic valves, mitral valve prolapse, 
hypertrophic cardiomyopathy, prior endocarditis, 
and presence of a prosthetic valve. 
• Local cardiac consequences include myocardial 
abscess, conduction system abnormalities, and 
sudden, severe valvular regurgitation.  
http://www.merckmanuals.com/professional/cardiovascular-disorders/endocarditis/infective-endocarditis 
Key Points 2 
• Systemic consequences include immune 
phenomena and septic emboli, which may affect 
any organ put particularly the lungs, kidneys, 
spleen, central nervous system (CNS), skin, retina. 
• Diagnose using blood cultures and Duke criteria. 
• Treat with a prolonged course of antimicrobial 
therapy; surgery may be needed for mechanical 
complications or resistant organisms. 
• Give antimicrobial prophylaxis for patients at high 
risk of an adverse outcome from infective 
endocarditis. 
http://www.merckmanuals.com/professional/cardiovascular-disorders/endocarditis/infective-endocarditis 
Abbreviations  
ABE - acute bacterial endocarditis  
ACE - angiotensin converting 
enzyme 
BE - bacterial endocarditis  
CMR - cardiac magnetic resonance 
CNS – central nervous system 
CRP - C-reactive protein  
CT - computed tomography   
ECG - electrocardiogram  
ESR - erythrocyte sedimentation 
rate  
IDU - injection drug use  
IE - infective endocarditis  
HIV - human immunodeficiency 
virus 
  
MIC - minimum inhibitory 
concentration  
MRI - magnetic resonance imaging 
NBTE - non-bacterial thrombotic 
endocarditis 
LVADs - left ventricular assistive 
devices  
PK/PD - 
pharmacokinetic/pharmacodynamic  
SBE - subacute bacterial endocarditis   
TEE - transesophageal 
echocardiography 
TTE - transthoracic echocardiography 
PET -  positron emission tomography 
Diagnostic and treatment guidelines 
2015 ESC Guidelines for the management of infective 
endocarditis 
Infective Endocarditis in Adults: Diagnosis, Antimicrobial 
Therapy, and Management of Complications 
Prophylaxis against infective endocarditis: antimicrobial 
prophylaxis against infective endocarditis in adults and children 
undergoing interventional procedures 
Infective Endocarditis 
Infective Endocarditis 
Cardiac imaging in infectious endocarditis 
 
